Skip Navigation

European Heart Journal 1995 16(Supplement L):8-10; doi:10.1093/eurheartj/16.suppl_L.8
Copyright © 1995 by the European Society of Cardiology.
This Article
Right arrow Full Text (PDF)
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Buller, H. R.
Right arrow Articles by Cate, J. W. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Buller, H. R.
Right arrow Articles by Cate, J. W. T.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1995 The European Scociety of Cardiology

Coagulation and platelet activation pathways

A review of the key components and the way in which these can be manipulated

H. R. Buller and J. W. Ten Cate

Center for Haemostasis Thrombosis, Atherosclerosis and Inflammation Research, Academic Medical Center, University of Amsterdam The Netherlands

Correspondence: Dr H. R. Büller, Center for Haemostasis, Thrombosis, Atherosclerosis and Inflammation Research, Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105 A2 Amsterdam, The Netherlands

Acute coronary syndromes are caused by thrombotic obstruction of usually diseased arteries The thrombotic plug consists of platelets and fibrin. Until recently only three antithrombotic drugs. aspirin, heparin and dicumarol were available for the prevention and treatment of acute coronary syndromes A better understanding of the cellular and humoral mechanisms underlying these syndromes has broadened the arsenal of antithrombotic drugs dramatically. In this review the physiological activation process of platelets and the coagulation cascade are discussed. Furthermore, the ways in which these processes can be therapeutically manipulated are reviewed.

Key Words: Platelets • coagulation • thrombosis


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.